Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide

Purpose: There is growing evidence showing that inflammatory cytokines and neuropeptides may be involved in the pathophysiology of suicidal behavior. However, studies have yielded contradictory data, and no biological markers that help predict suicide have been identified. This study aimed to identify biological patterns, such as NPY, IL-1 beta and hypocretin plasma levels, in people who died by suicide. Patients and methods: Twenty-two people who died by suicide compared with 22 controls matched for age and sex were studied. In suicide and control subjects, we estimated the levels of NPY, IL-1 beta and hypocretin in plasma using enzyme-linked immunosorbent assay. The data are presented as the median (25th-75th percentile). Results: We found (1) a significant elevation in plasma NPY levels in suicide subjects versus control subjects (suicide: 11.38 (9.380-16.55); controls: 8.95 (7.590-10.93); P=0.013), and plasma NPY concentrations were approximately 62% higher in suicide subjects than those in control subjects; (2) a significant decrease in plasma IL-1 beta concentrations between suicide and control subjects (suicide: 121.1 (82.97-143.0); controls: 425.9 (233.1-835.3); P<0.001) as well as a decrease in IL-1 beta concentrations by almost 80%; and (3) no significant difference in plasma hypocretin levels between suicide and control subjects (suicide: 16.62 (13.62-25.77); controls: 21.63 (14.97-29.72); P=0.356). Conclusion: Our results suggest that plasma NPY and IL-1 beta were related with suicide behavior rather than to suicide causes or suicide method. Specific combinations of plasma biomarkers may discriminate between types of suicidal behaviors and indicate increased risk for future suicide attempts.